Literature DB >> 11185846

Tracking managed care: the importance of a cash incentive for medical director response to a survey.

J L Malin1, J Rideout, P A Ganz.   

Abstract

OBJECTIVE: To assess the impact of a monetary incentive in a survey mailed to medical directors of large medical groups and independent practice associations (IPAs). STUDY
DESIGN: Mailed survey.
METHODS: We mailed a survey to the medical directors of all medical groups and IPAs contracted with Blue Cross California Care, a large California managed care health plan (n = 174). After 2 mailings without any monetary incentive, we included a $50 bill in the third mailing to increase the response rate.
RESULTS: Only 46 medical directors responded to the first and second mailings (response rates of 17% and 13%, respectively). The third mailing, which included a $50 bill attached to the front of the survey, yielded 78 responses (66%), for an overall total of 124 (76%). We found no significant differences in the physician organizations of medical directors who responded to the mailing with the $50 incentive compared with the physician organizations of those who responded to 1 of the first 2 mailings, although medical directors who responded without the financial incentive were more likely to report that their organization had staff for quality assurance (96% vs 82%; P < or = .03).
CONCLUSION: Including a $50 bill improved the rate of response to a survey mailed to medical directors from 13%-17% to 66%.

Mesh:

Year:  2000        PMID: 11185846

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  2 in total

1.  Effects of incentives and prenotification on response rates and costs in a national web survey of physicians.

Authors:  Jennifer Dykema; John Stevenson; Brendan Day; Sherrill L Sellers; Vence L Bonham
Journal:  Eval Health Prof       Date:  2011-05-24       Impact factor: 2.651

2.  The effect of a monetary incentive for administrative assistants on the survey response rate: a randomized controlled trial.

Authors:  Arnav Agarwal; Dany Raad; Victor Kairouz; John Fudyma; Anne B Curtis; Holger J Schünemann; Elie A Akl
Journal:  BMC Med Res Methodol       Date:  2016-08-05       Impact factor: 4.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.